Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis

ATS Statement

American Journal of Respiratory and Critical Care Medicine · 2002 · 10.5K citations

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Marc G. Achen, Michael Jeltsch, Eola Kukk et al. · Proceedings of the National Academy of Sciences · 1998 · 1.2K citations · Full text

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

Francis X. McCormack, Yoshikazu Inoue, Joel Moss et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · The Lancet · 2013 · 863 citations

Tuberous Sclerosis Complex, Sporadic Lymphangioleiomyomatosis, Pathology +4

Mutations in the tuberous sclerosis complex gene<i>TSC2</i>are a cause of sporadic pulmonary lymphangioleiomyomatosis

Thomas Carsillo, Aristotelis Astrinidis, Elizabeth P. Henske · Proceedings of the National Academy of Sciences · 2000 · 642 citations · Full text

Renal Pathology, Immunology, Pathology +16